Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Intravenous immunoglobulin versus observation in childhood immune thrombocytopenia: a randomized controlled trial.

Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, Tamminga RYJ, Smiers FJ, van Woerden NL, Wesseling J, Vidarsson G, Laarhoven AG, de Haas M, Bruin MCA.

Blood. 2018 Jun 26. pii: blood-2018-02-830844. doi: 10.1182/blood-2018-02-830844. [Epub ahead of print]

PMID:
29945954
2.

Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.

Zwiers C, van der Bom JG, van Kamp IL, Geloven NV, Lopriore E, Smoleniec J, Devlieger R, Sim PE, Ledingham MA, Tiblad E, Moise KJ Jr, Gloning KP, Kilby MD, Overton TG, Jørgensen DS, Schou KV, Paek B, Walker M, Parry E, Oepkes D, de Haas M.

Am J Obstet Gynecol. 2018 Jun 11. pii: S0002-9378(18)30494-0. doi: 10.1016/j.ajog.2018.06.007. [Epub ahead of print]

PMID:
29902448
3.

A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.

Rijkers M, Saris A, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Bierings R, Leebeek FWG, Jansen AJG, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2018 Jun 1. pii: haematol.2018.189365. doi: 10.3324/haematol.2018.189365. [Epub ahead of print]

4.

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art.

Porcelijn L, Huiskes E, Oldert G, Schipperus M, Zwaginga JJ, de Haas M.

Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15404. [Epub ahead of print]

PMID:
29808904
5.

Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks.

Brinkman EK, Chen T, de Haas M, Holland HA, Akhtar W, van Steensel B.

Mol Cell. 2018 Jun 7;70(5):801-813.e6. doi: 10.1016/j.molcel.2018.04.016. Epub 2018 May 24.

6.

Treatment and outcomes of fetal/neonatal alloimmune thrombocytopenia: a nationwide cohort study in newly detected cases.

Winkelhorst D, Oostweegel M, Porcelijn L, Middelburg RA, Zwaginga JJ, Oepkes D, van der Bom JG, de Haas M, Lopriore E.

Br J Haematol. 2018 Apr 16. doi: 10.1111/bjh.15216. [Epub ahead of print] No abstract available.

PMID:
29682737
7.

ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.

Zwiers C, Koelewijn JM, Vermij L, van Sambeeck J, Oepkes D, de Haas M, van der Schoot CE.

Transfusion. 2018 Apr 6. doi: 10.1111/trf.14606. [Epub ahead of print]

PMID:
29624682
8.

Immunoglobulin for alloimmune hemolytic disease in neonates.

Zwiers C, Scheffer-Rath ME, Lopriore E, de Haas M, Liley HG.

Cochrane Database Syst Rev. 2018 Mar 18;3:CD003313. doi: 10.1002/14651858.CD003313.pub2. Review.

PMID:
29551014
9.

Facilitators and barriers for RhD-immunized women to become and remain anti-D donors.

Slootweg YM, Koelewijn JM, de Kort WL, de Haas M, Merz EM.

Transfusion. 2018 Apr;58(4):960-968. doi: 10.1111/trf.14490. Epub 2018 Mar 12.

PMID:
29532485
10.

Acute hemolytic transfusion reaction due to a warm reactive anti-A1.

Helmich F, Baas I, Ligthart P, Bosch M, Jonkers F, de Haas M, van der Graaf F.

Transfusion. 2018 May;58(5):1163-1170. doi: 10.1111/trf.14537. Epub 2018 Feb 26.

PMID:
29484668
11.

Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport.

Stapleton NM, Armstrong-Fisher SS, Andersen JT, van der Schoot CE, Porter C, Page KR, Falconer D, de Haas M, Williamson LM, Clark MR, Vidarsson G, Armour KL.

Mol Immunol. 2018 Mar;95:1-9. doi: 10.1016/j.molimm.2018.01.006. Epub 2018 Feb 20.

12.

Human and murine splenic neutrophils are potent phagocytes of IgG-opsonized red blood cells.

Meinderts SM, Oldenborg PA, Beuger BM, Klei TRL, Johansson J, Kuijpers TW, Matozaki T, Huisman EJ, de Haas M, van den Berg TK, van Bruggen R.

Blood Adv. 2017 May 26;1(14):875-886. doi: 10.1182/bloodadvances.2017004671. eCollection 2017 Jun 13.

13.

Vox Sanguinis International Forum on application of fetal blood grouping: summary.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):198-201. doi: 10.1111/vox.12616. Epub 2017 Dec 28. No abstract available.

PMID:
29282745
14.

Vox Sanguinis International Forum on application of fetal blood grouping.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):e26-e35. doi: 10.1111/vox.12615. Epub 2017 Dec 28. No abstract available.

PMID:
29282741
15.

Genotyping to prevent Rh disease: has the time come?

van der Schoot CE, de Haas M, Clausen FB.

Curr Opin Hematol. 2017 Nov;24(6):544-550. doi: 10.1097/MOH.0000000000000379. Review.

PMID:
28937404
16.

Massive reshaping of genome-nuclear lamina interactions during oncogene-induced senescence.

Lenain C, de Graaf CA, Pagie L, Visser NL, de Haas M, de Vries SS, Peric-Hupkes D, van Steensel B, Peeper DS.

Genome Res. 2017 Oct;27(10):1634-1644. doi: 10.1101/gr.225763.117. Epub 2017 Sep 15.

17.

Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.

Sonneveld ME, de Haas M, Koeleman C, de Haan N, Zeerleder SS, Ligthart PC, Wuhrer M, van der Schoot CE, Vidarsson G.

Sci Rep. 2017 Aug 15;7(1):8187. doi: 10.1038/s41598-017-08654-y.

18.

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients.

Porcelijn L, Huiskes E, Schipperus M, van der Holt B, de Haas M, Zwaginga JJ; Dutch HOVON 64 Study Group.

Blood. 2017 Jun 22;129(25):3389-3391. doi: 10.1182/blood-2016-11-751719. Epub 2017 May 3. No abstract available.

19.

Absence of the spleen and the occurrence of primary red cell alloimmunization in humans.

Evers D, van der Bom JG, Tijmensen J, de Haas M, Middelburg RA, de Vooght KMK, van de Kerkhof D, Visser O, Péquériaux NCV, Hudig F, Zwaginga JJ.

Haematologica. 2017 Aug;102(8):e289-e292. doi: 10.3324/haematol.2016.162685. Epub 2017 Apr 14. No abstract available.

20.

Women's attitude towards routine human platelet antigen-screening in pregnancy.

Winkelhorst D, Loeff RM, van den Akker-Van Marle ME, de Haas M, Oepkes D.

Acta Obstet Gynecol Scand. 2017 Aug;96(8):991-997. doi: 10.1111/aogs.13150. Epub 2017 May 16.

PMID:
28401538
21.

Child-Robot Interactions for Second Language Tutoring to Preschool Children.

Vogt P, de Haas M, de Jong C, Baxter P, Krahmer E.

Front Hum Neurosci. 2017 Mar 2;11:73. doi: 10.3389/fnhum.2017.00073. eCollection 2017.

22.

RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance.

Stegmann TC, Veldhuisen B, Nagelkerke SQ, Winkelhorst D, Schonewille H, Verduin EP, Kuijpers TW, de Haas M, Vidarsson G, van der Schoot CE.

Blood. 2017 Feb 23;129(8):1045-1048. doi: 10.1182/blood-2016-05-716365. Epub 2017 Jan 12. No abstract available.

23.

Genome-wide mapping of autonomous promoter activity in human cells.

van Arensbergen J, FitzPatrick VD, de Haas M, Pagie L, Sluimer J, Bussemaker HJ, van Steensel B.

Nat Biotechnol. 2017 Feb;35(2):145-153. doi: 10.1038/nbt.3754. Epub 2016 Dec 26.

24.

Requests for red cells with rare blood types in the Netherlands.

Luken JS, Danovic F, de Haas M, Koopman R.

Immunohematology. 2016 Jun;32(2):51-52. Review. No abstract available.

PMID:
27901566
25.

Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.

Sonneveld ME, Koelewijn J, de Haas M, Admiraal J, Plomp R, Koeleman CA, Hipgrave Ederveen AL, Ligthart P, Wuhrer M, van der Schoot CE, Vidarsson G.

Br J Haematol. 2017 Feb;176(4):651-660. doi: 10.1111/bjh.14438. Epub 2016 Nov 28.

PMID:
27891581
26.

Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.

de Haas M, Thurik FF, van der Ploeg CP, Veldhuisen B, Hirschberg H, Soussan AA, Woortmeijer H, Abbink F, Page-Christiaens GC, Scheffer PG, Ellen van der Schoot C.

BMJ. 2016 Nov 7;355:i5789. doi: 10.1136/bmj.i5789.

27.

Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.

Zwiers C, Lindenburg ITM, Klumper FJ, de Haas M, Oepkes D, Van Kamp IL.

Ultrasound Obstet Gynecol. 2017 Aug;50(2):180-186. doi: 10.1002/uog.17319.

28.

Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.

Evers D, Zwaginga JJ, Tijmensen J, Middelburg RA, de Haas M, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, van der Bom JG.

Haematologica. 2017 Jan;102(1):52-59. doi: 10.3324/haematol.2016.152074. Epub 2016 Sep 15.

29.

Red cell alloimmunisation in patients with different types of infections.

Evers D, van der Bom JG, Tijmensen J, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Zwaginga JJ.

Br J Haematol. 2016 Dec;175(5):956-966. doi: 10.1111/bjh.14307. Epub 2016 Aug 18.

PMID:
27539877
30.

International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

Storry JR, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Keller M, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Peyrard T, van der Schoot CE, Tani Y, Thornton N, Wagner F, Wendel S, Westhoff C, Yahalom V.

ISBT Sci Ser. 2016 Aug;11(2):118-122. doi: 10.1111/voxs.12280. Epub 2016 Jun 27.

31.

Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.

Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Schonewille H, Zwaginga JJ, van der Bom JG.

Lancet Haematol. 2016 Jun;3(6):e284-92. doi: 10.1016/S2352-3026(16)30019-9. Epub 2016 May 9.

PMID:
27264038
32.

Fetal RHD genotyping after bone marrow transplantation.

Thurik FF, Page-Christiaens GC, Ait Soussan A, Ligthart PC, Cheroutre GM, Bossers B, Veldhuisen B, van der Schoot CE, de Haas M.

Transfusion. 2016 Aug;56(8):2122-6. doi: 10.1111/trf.13669. Epub 2016 May 30.

PMID:
27239725
33.

Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.

Sins JW, Biemond BJ, van den Bersselaar SM, Heijboer H, Rijneveld AW, Cnossen MH, Kerkhoffs JL, van Meurs AH, von Ronnen FB, Zalpuri S, de Rijke YB, Ellen van der Schoot C, de Haas M, van der Bom JG, Fijnvandraat K.

Am J Hematol. 2016 Aug;91(8):763-9. doi: 10.1002/ajh.24397. Epub 2016 May 24.

34.

Update on the nomenclature of human neutrophil antigens and alleles.

Flesch BK, Curtis BR, de Haas M, Lucas G, Sachs UJ.

Transfusion. 2016 Jun;56(6):1477-9. doi: 10.1111/trf.13575. Epub 2016 Apr 4. No abstract available.

PMID:
27039828
35.

Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.

Stegmann TC, Veldhuisen B, Bijman R, Thurik FF, Bossers B, Cheroutre G, Jonkers R, Ligthart P, de Haas M, Haer-Wigman L, van der Schoot CE.

Br J Haematol. 2016 May;173(3):469-79. doi: 10.1111/bjh.13960. Epub 2016 Mar 27.

PMID:
27018217
36.

Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.

Slootweg YM, Koelewijn JM, van Kamp IL, van der Bom JG, Oepkes D, de Haas M.

BJOG. 2016 May;123(6):955-63. doi: 10.1111/1471-0528.13816. Epub 2015 Dec 11.

37.

ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs.

Jansen RS, Mahakena S, de Haas M, Borst P, van de Wetering K.

J Biol Chem. 2015 Dec 18;290(51):30429-40. doi: 10.1074/jbc.M115.692103. Epub 2015 Oct 29.

38.
39.

Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies.

Meulenbroek EM, de Haas M, Brouwer C, Folman C, Zeerleder SS, Wouters D.

Haematologica. 2015 Nov;100(11):1407-14. doi: 10.3324/haematol.2015.128991. Epub 2015 Sep 9.

40.

Haemolytic disease of the fetus and newborn.

de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE.

Vox Sang. 2015 Aug;109(2):99-113. doi: 10.1111/vox.12265. Epub 2015 Apr 20. Review.

PMID:
25899660
41.

[Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].

van der Ploeg CP, Hirschberg HJ, de Haas M, Abbink F.

Ned Tijdschr Geneeskd. 2015;159:A8315. Dutch.

PMID:
25898866
42.

Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy.

Thurik FF, Ait Soussan A, Bossers B, Woortmeijer H, Veldhuisen B, Page-Christiaens GC, de Haas M, van der Schoot CE.

Prenat Diagn. 2015 Aug;35(8):754-60. doi: 10.1002/pd.4600. Epub 2015 May 19.

PMID:
25855535
43.

Impact of genetic variation in the SMIM1 gene on Vel expression levels.

Haer-Wigman L, Stegmann TC, Solati S, Ait Soussan A, Beckers E, van der Harst P, van Hulst-Sundermeijer M, Ligthart P, van Rhenen D, Schepers H, de Haas M, van der Schoot CE.

Transfusion. 2015 Jun;55(6 Pt 2):1457-66. doi: 10.1111/trf.13014. Epub 2015 Feb 3.

PMID:
25647324
44.

Growth factor-induced osteogenesis in a novel radiolucent bone chamber.

Poldervaart MT, van der Stok J, de Haas MF, 't Hart MC, Öner FC, Dhert WJ, Weinans H, Alblas J.

Eur Cell Mater. 2015 Jan 2;29:35-41; discussion 41.

45.

C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia.

Kapur R, Heitink-Pollé KM, Porcelijn L, Bentlage AE, Bruin MC, Visser R, Roos D, Schasfoort RB, de Haas M, van der Schoot CE, Vidarsson G.

Blood. 2015 Mar 12;125(11):1793-802. doi: 10.1182/blood-2014-05-579110. Epub 2014 Dec 29.

46.

Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis.

Heitink-Pollé KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC.

Blood. 2014 Nov 20;124(22):3295-307. doi: 10.1182/blood-2014-04-570127. Epub 2014 Oct 10. Review.

47.

Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.

Kapur R, Della Valle L, Verhagen OJ, Hipgrave Ederveen A, Ligthart P, de Haas M, Kumpel B, Wuhrer M, van der Schoot CE, Vidarsson G.

Transfusion. 2015 Mar;55(3):553-62. doi: 10.1111/trf.12880. Epub 2014 Sep 19.

PMID:
25234110
48.

Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.

Ji Y, Veldhuisen B, Ligthart P, Haer-Wigman L, Jongerius J, Boujnan M, Ait Soussan A, Luo G, Fu Y, van der Schoot CE, de Haas M.

Transfusion. 2015 Feb;55(2):413-21. doi: 10.1111/trf.12838. Epub 2014 Aug 25.

PMID:
25156717
49.

Anti-D prophylaxis: past, present and future.

de Haas M, Finning K, Massey E, Roberts DJ.

Transfus Med. 2014 Feb;24(1):1-7. Review.

PMID:
25121157
50.

Management and outcome of 35 cases with foetal/neonatal alloimmune neutropenia.

van den Tooren-de Groot R, Ottink M, Huiskes E, van Rossum A, van der Voorn B, Slomp J, de Haas M, Porcelijn L.

Acta Paediatr. 2014 Nov;103(11):e467-74. doi: 10.1111/apa.12741. Epub 2014 Jul 29.

PMID:
25039288

Supplemental Content

Loading ...
Support Center